SELLAS Life Sciences Group, Inc. (SLS) Financials

$1.61

$0.05 (-3.01%)
Last update: 01:43 PM EST
Day's range
$1.58
Day's range
$1.71
$10M$10M$0$0-$10M-$10M-$20M-$20M-$30M-$30M-$40M-$40M-$50M-$50MEarning201820182019201920202020202120212022202220232023202420240%0%-1000%-1000%-2000%-2000%-3000%-3000%-4000%-4000%-5000%-5000%-6000%-6000%Profit Margin
Profit Margin
Revenue
Earnings

SLS Income statement / Annual

Last year (2024), SELLAS Life Sciences Group, Inc.'s total revenue was $0.00, and the percentage change from the previous year is not available. In 2024, SELLAS Life Sciences Group, Inc.'s net income was -$30.88 M. See SELLAS Life Sciences Group, Inc.,s key income statements, including revenue, expenses, profit, and income.

Period FY-2024 FY-2023 FY-2022 FY-2021 FY-2020 FY-2019 FY-2018 FY-2017 FY-2016 FY-2015
Period Ended 12/31/2024 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019 12/31/2018 12/31/2017 12/31/2016 12/31/2015
Operating Revenue $0.00 $0.00 $1.00 M $7.60 M $1.90 M $0.00 $0.00 $0.00 $0.00 $0.00
Cost of Revenue $0.00 $0.00 $100.00 K $200.00 K $377.00 K $0.00 $0.00 $0.00 $3.00 K $355.00 K
Gross Profit $0.00 $0.00 $900.00 K $7.40 M $1.90 M $0.00 $0.00 $0.00 -$3.00 K -$355.00 K
Gross Profit Ratio 0 0 0.9 0.97 1 0 0 0 0 0
Research and Development Expenses $19.10 M $24.01 M $30.27 M $21.37 M $9.28 M $7.29 M $18.32 M $6.07 M $19.86 M $23.61 M
General & Administrative Expenses $12.42 M $13.86 M $12.58 M $11.32 M $9.60 M $9.92 M $12.77 M $15.09 M $12.01 M $10.61 M
Selling & Marketing Expenses $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Selling, General & Administrative Expenses $12.42 M $13.86 M $12.58 M $11.32 M $9.60 M $9.92 M $12.77 M $15.09 M $12.01 M $10.25 M
Other Expenses $0.00 $0.00 $10.00 M $5.70 M $0.00 $0.00 -$3.03 M $0.00 $0.00 $509.00 K
Operating Expenses $31.51 M $37.87 M $42.85 M $32.69 M $18.88 M $17.21 M $31.59 M $21.16 M $31.87 M $33.87 M
Cost And Expenses $0.00 $37.87 M $42.95 M $32.89 M $18.88 M $17.21 M $31.09 M $21.16 M $31.87 M $34.22 M
Interest Income $632.00 K $525.00 K $317.00 K $6.00 K $26.00 K $118.00 K $0.00 $0.00 $0.00 $0.00
Interest Expense $0.00 $0.00 $0.00 $0.00 $0.00 $118.00 K $266.00 K $462.00 K $3.51 M $760.00 K
Depreciation & Amortization $31.51 M $37.87 M $457.00 K $1.27 M $282.00 K $17.21 M $22.04 M $3.00 K $3.00 K $355.00 K
EBITDA -$30.88 M $529.00 K -$31.95 M -$19.59 M -$16.40 M $668.00 K $0.00 -$23.04 M -$15.99 M -$37.48 M
EBITDA Ratio 0 0 -31.95 -2.58 -8.63 0 0 0 0 0
Operating Income Ratio 0 0 -41.95 -3.33 -8.94 0 0 0 0 0
Total Other Income/Expenses Net $632.00 K $529.00 K $649.00 K $4.36 M $208.00 K $668.00 K $2.54 M -$7.79 M $5.13 M -$4.37 M
Income Before Tax -$30.88 M -$37.34 M -$41.30 M -$20.94 M -$16.77 M -$19.37 M -$29.05 M -$23.50 M -$17.68 M -$38.59 M
Income Before Tax Ratio 0 0 -41.3 -2.75 -8.83 0 0 0 0 0
Income Tax Expense $0.00 $0.00 -$649.00 K -$237.00 K -$17.00 K -$81.00 K -$1.38 M $253.00 K $243.00 K $365.00 K
Net Income -$30.88 M -$37.34 M -$41.30 M -$20.70 M -$16.76 M -$19.29 M -$27.67 M -$23.75 M -$23.55 M -$63.90 M
Net Income Ratio 0 0 -41.3 -2.72 -8.82 0 0 0 0 0
EPS -0.0505 -0.15 -2.13 -1.34 -2.11 -0.84 -11.76 -56.39 -394.12 -1372.03
EPS Diluted -0.0505 -0.15 -2.13 -1.34 -2.11 -0.84 -11.76 -56.39 -394.12 -1372.02
Weighted Average Shares Out $612.02 M $249.99 M $19.40 M $15.48 M $7.98 M $23.03 M $2.35 M $45.00 K $59.75 K $46.57 K
Weighted Average Shares Out Diluted $612.02 M $249.99 M $19.40 M $15.48 M $7.98 M $23.03 M $2.35 M $46.81 K $59.75 K $46.58 K
Link